These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 29282151)

  • 1. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer].
    Bay JO; André T; Caux C; Evrard S; Gonçalves A; L'Allemain G; Magné N; Orbach D; Penel N; Rodrigues M; Thariat J; Thiery-Vuillemin A; Wislez M;
    Bull Cancer; 2019 Jan; 106(1):12-23. PubMed ID: 30612698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials in the era of personalized oncology.
    Maitland ML; Schilsky RL
    CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Personalized Medicine in the Canadian Environment: Efforts Facilitating Oncology Clinical Research.
    Syme R; Carleton B; Leyens L; Richer E
    Public Health Genomics; 2015; 18(6):372-80. PubMed ID: 26565702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and challenges in immuno-oncology trials.
    Kiernan B
    Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].
    Vignot S; André T; Caux C; Bouleuc C; Evrard S; Gonçalves A; Lacroix M; Magné N; Massard C; Mazeron JJ; Orbach D; Rodrigues M; Thariat J; Wislez M; L'Allemain G; Bay JO
    Bull Cancer; 2018 Jan; 105(1):6-14. PubMed ID: 29269176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology.
    Lee RT; Yang P; Greenlee H; Bauer-Wu S; Balneaves LG; Zick S
    Integr Cancer Ther; 2015 Jan; 14(1):98-105. PubMed ID: 25505022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-Oncology in the Era of Personalized Medicine.
    Gwin WR; Disis ML; Ruiz-Garcia E
    Adv Exp Med Biol; 2019; 1168():117-129. PubMed ID: 31713168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape of early clinical trials for childhood and adolescence cancer in Spain.
    Bautista F; Gallego S; Cañete A; Mora J; Diaz de Heredia C; Cruz O; Fernández JM; Rives S; Madero L; Castel V; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L
    Clin Transl Oncol; 2016 Jul; 18(7):708-13. PubMed ID: 26489424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hubris and humility of cancer pharmacology in the post immuno-oncology era.
    Lazo JS
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00527. PubMed ID: 31624635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of oncology therapeutics.
    Mansinho A; Boni V; de Miguel M; Calvo E
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical cancer research: the past, present and the future.
    DeVita VT; Eggermont AM; Hellman S; Kerr DJ
    Nat Rev Clin Oncol; 2014 Nov; 11(11):663-9. PubMed ID: 25245981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-oncology for surgeons.
    Lee SL; Al-Shamkhani A; Mirnezami A
    Br J Surg; 2019 Sep; 106(10):1273-1282. PubMed ID: 31318438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies.
    Siu LL; Ivy SP; Dixon EL; Gravell AE; Reeves SA; Rosner GL
    Clin Cancer Res; 2017 Sep; 23(17):4950-4958. PubMed ID: 28864723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onco-omics Approaches and Applications in Clinical Trials for Cancer Patients.
    Hernandez-Martinez JM; Sánchez-Reyes R; De la Garza-Salazar JG; Arrieta O
    Adv Exp Med Biol; 2019; 1168():79-90. PubMed ID: 31713165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.